A new method of targeting and destroying cancer cells was outlined during a recent presentation made at the 63rd annual meeting of the American Physical Society. This method of destroying cancer cells is based on increasing the temperature of these cancer cells, whilst ensuring that healthy tissue surrounding these cancer cells remains at normal body [...]

A recent study into a gene that was previously known to play a part in the development and growth of tumor cells, found that this gene also protected cancerous cells from the effects of chemotherapy. The researchers conducting this study believe that the inhibition of the expression of this gene could provide an effective means [...]

The results of a recent study, conducted by researchers at the Dana-Farber Cancer Institute, highlighted the importance of using treatment strategies that are personalized to individual patients in the treatment of genetically defined cancers. The researchers reported that they had managed to achieve significant results in terms treating a rare and aggressive form of soft-tissue [...]

The results of a recent study indicate that a new form of treatment known as immunotherapy, which involves the use of biologic agents that stimulate the body’s immune system, was found to be effective in the treatment of neuroblastoma. Neuroblastoma is a cancer of the peripheral nervous system that usually appears in the form of [...]

Hospira, Inc., the global leader in the production of generic injectable pharmaceuticals, which also boasts one of the broadest portfolios of generic acute-care and oncology injectables in the world, recently announced the approval of its biosimilar filgrastim product, Nivestim, for distribution in Australia, by the Therapeutic Goods Administration (TGA) of Australia. The TGA granted approval [...]

A study recently published in Blood, the journal of the American Society of Hematology, outlined a new enhanced risk model to predict likelihood of blood clots developing in cancer patients, who are more likely to develop venous thromboembolism (VTE) due to a hyperactive blood coagulation system. Around 20 percent of all cancer patients develop VTE, [...]

Lung cancer risk may be lowered by vitamin B6 and methionine. This is according to a new study by scientists who studied more than 400,000 people to establish the relation between lung cancer and the amount of vitamin B6 and methionine. In the study, blood samples were drawn from the participants and analyzed for the [...]